Movement Alert|Tempus AI Drops 5.04% in Regular Trading, CEO Files to Sell $14M in Shares Triggering Reversal After Intraday Surge

Market Focus09-18 23:11

On September 18, Tempus AI fell 5.04% in regular trading to $76.31 per share, with turnover of approximately $293 million. Notably, the stock had surged as much as 14% intraday before reversing sharply into negative territory.

The reversal was triggered by a Form 144 filing revealing that CEO and Chairman Eric Lefkofsky plans to sell 200,000 shares of Class A common stock through J.P. Morgan Securities LLC on NASDAQ, valued at approximately $13.994 million. This marks the third such filing in recent months, following a 250,000-share disposal in late August and another 249,000-share sale in late July, all executed under a pre-arranged Rule 10b5-1 trading plan.

Despite a string of recent catalysts — including the announcement of the world's largest multimodal whole-genome dataset, FDA clearance for its AI-enabled pulmonary hypertension detector, up to $9.5 million in ARPA-H funding for a cardiology AI agent, and Q2 results that beat estimates on both revenue ($382.5M vs. $379.7M est.) and adjusted EPS (-$0.04 vs. -$0.14 est.) — repeated insider selling amid a rapid four-session rally of over 36% intensified profit-taking pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment